FullHope Biomedical Co (ROCO:7773) EV-to-EBIT : -17.72 (As of May. 30, 2025)

View and export this data going back to 2024. Start your Free Trial

What is FullHope Biomedical Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, FullHope Biomedical Co's Enterprise Value is NT$987.46 Mil. FullHope Biomedical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-55.74 Mil. Therefore, FullHope Biomedical Co's EV-to-EBIT for today is -17.72.

The historical rank and industry rank for FullHope Biomedical Co's EV-to-EBIT or its related term are showing as below:

ROCO:7773' s EV-to-EBIT Range Over the Past 10 Years
Min: -33.28 Med: -18.29 Max: -12.25
Current: -17.71

During the past 4 years, the highest EV-to-EBIT of FullHope Biomedical Co was -12.25. The lowest was -33.28. And the median was -18.29.

ROCO:7773's EV-to-EBIT is ranked worse than
100% of 473 companies
in the Biotechnology industry
Industry Median: 8.26 vs ROCO:7773: -17.71

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. FullHope Biomedical Co's Enterprise Value for the quarter that ended in Dec. 2024 was NT$1,015.39 Mil. FullHope Biomedical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-55.74 Mil. FullHope Biomedical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -5.49%.

FullHope Biomedical Co EV-to-EBIT Historical Data

The historical data trend for FullHope Biomedical Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FullHope Biomedical Co EV-to-EBIT Chart

FullHope Biomedical Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

EV-to-EBIT

-18.22

FullHope Biomedical Co Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-EBIT	Get a 7-Day Free Trial			-	-	-	-	-18.22

Competitive Comparison of FullHope Biomedical Co's EV-to-EBIT

For the Biotechnology subindustry, FullHope Biomedical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FullHope Biomedical Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FullHope Biomedical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where FullHope Biomedical Co's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

FullHope Biomedical Co EV-to-EBIT Calculation

FullHope Biomedical Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	987.460	/	-55.737
	=	-17.72

FullHope Biomedical Co's current Enterprise Value is NT$987.46 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. FullHope Biomedical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-55.74 Mil.

FullHope Biomedical Co (ROCO:7773) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

FullHope Biomedical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 )	=	EBIT	/	Enterprise Value (Q: Dec. 2024 )
	=	-55.737	/	1015.38965
	=	-5.49 %

FullHope Biomedical Co's Enterprise Value for the quarter that ended in Dec. 2024 was NT$1,015.39 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. FullHope Biomedical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-55.74 Mil.

FullHope Biomedical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of FullHope Biomedical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

FullHope Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FullHope Biomedical Co Ltd (ROCO:7773) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN

Website

https://www.fhb.com.tw

FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.

FullHope Biomedical Co Headlines

No Headlines